Olszewski BJ - Search Results

1

Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.

Ryan MJ, Boucher DM, Cohen DM, Olszewski BJ, Singer RM, Smith RD, Kaplan HR. Ryan MJ, et al. Among authors: olszewski bj. Fed Proc. 1984 Apr;43(5):1330-2. Fed Proc. 1984. PMID: 6323224

2

Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.

Ryan MJ, Boucher DM, Cohen DM, Essenburg AD, Major TC, Mertz TE, Olszewski BJ, Randolph AE, Singer RM, Kaplan HR. Ryan MJ, et al. Among authors: olszewski bj. J Pharmacol Exp Ther. 1984 Feb;228(2):312-8. J Pharmacol Exp Ther. 1984. PMID: 6319675

3

CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology.

Ryan MJ, Bjork FA, Cohen DM, Coughenour LL, Major TC, Mathias NP, Mertz TE, Olszewski BJ, Singer RM, Evans DB, et al. Ryan MJ, et al. Among authors: olszewski bj. J Pharmacol Exp Ther. 1986 Aug;238(2):473-9. J Pharmacol Exp Ther. 1986. PMID: 2874210

4

Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms.

Low JE, Metz AL, Mertz TE, Henry SP, Knowlton P, Loewen G, Sommers CS, Robertson DG, Olszewski BJ, Schroeder RL, et al. Low JE, et al. Among authors: olszewski bj. J Cardiovasc Pharmacol. 1995 Jun;25(6):930-9. doi: 10.1097/00005344-199506000-00011. J Cardiovasc Pharmacol. 1995. PMID: 7564338

5

A CCR2/CCR5 antagonist attenuates an increase in angiotensin II-induced CD11b+ monocytes from atherogenic ApoE-/- mice.

Major TC, Olszewski B, Rosebury-Smith WS. Major TC, et al. Cardiovasc Drugs Ther. 2009 Apr;23(2):113-20. doi: 10.1007/s10557-008-6157-0. Epub 2008 Dec 4. Cardiovasc Drugs Ther. 2009. PMID: 19052854

6

A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.

Major TC, Olszewski B, Rosebury W, Okerberg C, Carlson T, Ostroski R, Schroeder R, Kowala MC, Leadley R. Major TC, et al. Cardiovasc Drugs Ther. 2008 Dec;22(6):469-78. doi: 10.1007/s10557-008-6131-x. Epub 2008 Aug 5. Cardiovasc Drugs Ther. 2008. PMID: 18679781

7

Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist.

Reynolds EE, Keiser JA, Haleen SJ, Walker DM, Olszewski B, Schroeder RL, Taylor DG, Hwang O, Welch KM, Flynn MA, et al. Reynolds EE, et al. J Pharmacol Exp Ther. 1995 Jun;273(3):1410-7. J Pharmacol Exp Ther. 1995. PMID: 7791115

8

Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression.

Wang H, Olszewski B, Rosebury W, Wang D, Robertson A, Keiser JA. Wang H, et al. Biochem Biophys Res Commun. 2004 Mar 5;315(2):363-8. doi: 10.1016/j.bbrc.2004.01.059. Biochem Biophys Res Commun. 2004. PMID: 14766216

9

Dose-dependent neovascularization-promoting effect of adenovirus vector CI-1023 in a rat hindlimb ischaemic model.

Wang H, Keiser JA, Olszewski B, Brammer D, Gordon D. Wang H, et al. Basic Clin Pharmacol Toxicol. 2004 Aug;95(2):76-80. doi: 10.1111/j.1742-7843.2004.950206.x. Basic Clin Pharmacol Toxicol. 2004. PMID: 15379784 Free article.

10

Delayed angiogenesis in aging rats and therapeutic effect of adenoviral gene transfer of VEGF.

Wang H, Keiser JA, Olszewski B, Rosebury W, Robertson A, Kovesdi I, Gordon D. Wang H, et al. Int J Mol Med. 2004 Apr;13(4):581-7. Int J Mol Med. 2004. PMID: 15010860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters